The short version
9 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.8144 per mL over the past year. It is in shortage right now — FDA lists the reason as “other”.
Market view
hydroxocobalamin
17 marketed package NDCs · 9 active manufacturers
Most dispensed: ACETATE 1000 ug/mL · Injection, Solution · #1 vial, multi-dose/carton / 30 ml in 1 vial, multi-dose
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.8144 · middle half $0.8144–$0.8144 · full range $0.8144–$0.8144 · 1 products · 9 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Same drug class
Other molecules FDA puts in Antidote, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- acetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -· 1 maker
- multivitamin· 2 makers
- fomepizole· 10 makers
- acetylcysteine· 24 makers
Common questions
- Is Hydroxocobalamin in shortage right now?
- Yes. FDA currently lists Hydroxocobalamin in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
- Who makes Hydroxocobalamin?
- 9 companies have marketed Hydroxocobalamin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Hydroxocobalamin cost?
- The typical pharmacy pays about $0.8144 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- In shortage now — Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)Nov 4, 2024
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.